| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1028891107 |
| P356 | DOI | 10.1038/35039551 |
| P3181 | OpenCitations bibliographic resource ID | 2979114 |
| P698 | PubMed publication ID | 11069186 |
| P5875 | ResearchGate publication ID | 12258805 |
| P50 | author | Tom Blundell | Q7814993 |
| Frank von Delft | Q28050592 | ||
| David F Burke | Q56419422 | ||
| P2093 | author name string | Mulloy B | |
| Pellegrini L | |||
| P2860 | cites work | Structural basis for FGF receptor dimerization and activation | Q22010544 |
| Structural interactions of fibroblast growth factor receptor with its ligands | Q22011005 | ||
| N.m.r. and molecular-modelling studies of the solution conformation of heparin | Q24528140 | ||
| Improved methods for building protein models in electron density maps and the location of errors in these models | Q26776980 | ||
| Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination | Q26778405 | ||
| Processing of X-ray diffraction data collected in oscillation mode | Q26778468 | ||
| Heparin structure and interactions with basic fibroblast growth factor | Q27732601 | ||
| Structure of a heparin-linked biologically active dimer of fibroblast growth factor | Q27760195 | ||
| Methods used in the structure determination of bovine mitochondrial F1 ATPase | Q27860644 | ||
| Three-Dimensional Structures of Acidic and Basic Fibroblast Growth Factors | Q28267322 | ||
| Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation | Q28296150 | ||
| Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex | Q34452252 | ||
| Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells | Q38331586 | ||
| Glu-96 of basic fibroblast growth factor is essential for high affinity receptor binding. Identification by structure-based site-directed mutagenesis | Q46277587 | ||
| Side-chain effects on peptidyl-prolyl cis/trans isomerisation. | Q47923607 | ||
| Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation | Q54246457 | ||
| Analysis of high-affinity binding determinants in the receptor binding epitope of basic fibroblast growth factor. | Q54568041 | ||
| [27] Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods. | Q55059918 | ||
| Genotype-phenotype correlation for nucleotide substitutions in the IgII- IgIII linker of FGFR2 | Q56263821 | ||
| An essential heparin-binding domain in the fibroblast growth factor receptor kinase | Q70619107 | ||
| Ligand-specific structural domains in the fibroblast growth factor receptor | Q72191030 | ||
| Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain | Q72326632 | ||
| Fibroblast growth factors and their receptors | Q74584667 | ||
| High-performance liquid chromatographic separation of heparin-derived oligosaccharides | Q93681630 | ||
| P433 | issue | 6807 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heparin | Q190016 |
| crystal structure | Q895901 | ||
| P304 | page(s) | 1029-1034 | |
| P577 | publication date | 2000-10-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin | |
| P478 | volume | 407 |
| Q51572127 | 19F labelled glycosaminoglycan probes for solution NMR and non-linear (CARS) microscopy. |
| Q58061923 | 1H, 13C and 15N assignment of D2 domain of human fibroblast growth factor receptor 4 |
| Q35663605 | 2-O Heparan Sulfate Sulfation by Hs2st Is Required for Erk/Mapk Signalling Activation at the Mid-Gestational Mouse Telencephalic Midline. |
| Q27316362 | 3-OST-7 regulates BMP-dependent cardiac contraction |
| Q38293479 | 6-O-sulfation of heparan sulfate differentially regulates various fibroblast growth factor-dependent signalings in culture |
| Q42170088 | A Biocompatible Arginine-based Polycation. |
| Q35148242 | A bioactive self-assembled membrane to promote angiogenesis. |
| Q47339281 | A biocompatible betaine-functionalized polycation for coacervation. |
| Q27647900 | A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist |
| Q36275692 | A molecular dynamics-based algorithm for evaluating the glycosaminoglycan mimicking potential of synthetic, homogenous, sulfated small molecules |
| Q24308849 | A molecular mechanism for the heparan sulfate dependence of slit-robo signaling |
| Q30356926 | A network-based analysis of polyanion-binding proteins utilizing yeast protein arrays. |
| Q27639093 | A new crystal form of the NK1 splice variant of HGF/SF demonstrates extensive hinge movement and suggests that the NK1 dimer originates by domain swapping |
| Q42810651 | A peptide from the first fibronectin domain of NCAM acts as an inverse agonist and stimulates FGF receptor activation, neurite outgrowth and survival |
| Q40680425 | A role for chondroitin sulphate B in the activity of interleukin 12 in stimulating gamma-interferon secretion |
| Q41895425 | A role for the perlecan protein core in the activation of the keratinocyte growth factor receptor |
| Q27642593 | Accommodation of a highly symmetric core within a symmetric protein superfold |
| Q36798972 | Achieving high signal-to-noise in cell regulatory systems: Spatial organization of multiprotein transmembrane assemblies of FGFR and MET receptors. |
| Q42784197 | Activation of heat shock response augments fibroblast growth factor-1 expression in wounded lung epithelium |
| Q27469802 | Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo |
| Q37341011 | Adhesion proteins meet receptors: a common theme? |
| Q45919172 | Agonists of fibroblast growth factor receptor induce neurite outgrowth and survival of cerebellar granule neurons. |
| Q27637812 | Alternative type I and I' turn conformations in the beta8/beta9 beta-hairpin of human acidic fibroblast growth factor |
| Q36481630 | An Introduction to Proteoglycans and Their Localization |
| Q38290536 | An S116R Phosphorylation Site Mutation in Human Fibroblast Growth Factor-1 Differentially Affects Mitogenic and Glucose-Lowering Activities |
| Q24557572 | Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization |
| Q54447405 | Analysis of the fibroblast growth factor receptor (FGFR) signalling network with heparin as coreceptor: evidence for the expansion of the core FGFR signalling network |
| Q53584662 | Antiangiogenic effect of bile acid acylated heparin derivative |
| Q41221244 | Antibody-induced dimerization of FGFR1 promotes receptor endocytosis independently of its kinase activity |
| Q39108532 | Approaches for building bioactive elements into synthetic scaffolds for bone tissue engineering. |
| Q57918839 | Asymmetry in the Multiprotein Systems of Molecular Biology |
| Q38310289 | Backbone dynamics of a biologically active human FGF-1 monomer, complexed to a hexasaccharide heparin-analogue, by 15N NMR relaxation methods. |
| Q24296762 | Basic residues in azurocidin/HBP contribute to both heparin binding and antimicrobial activity |
| Q38302571 | Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4. |
| Q34030882 | Bioinformatics and molecular modeling in glycobiology. |
| Q37216313 | Biological implications of glycosaminoglycan interactions with haemopoietic cytokines. |
| Q47332307 | Biomaterial strategies for limiting the impact of secondary events following spinal cord injury. |
| Q24535653 | Biosynthesis of heparan sulphate with diverse structures and functions: two alternatively spliced forms of human heparan sulphate 6-O-sulphotransferase-2 having different expression patterns and properties |
| Q24311571 | Bivalent and co-operative binding of complement factor H to heparan sulfate and heparin |
| Q45966817 | Blockade of Nonhormonal Fibroblast Growth Factors by FP-1039 Inhibits Growth of Multiple Types of Cancer |
| Q24297423 | Cell responses to FGFR3 signalling: growth, differentiation and apoptosis |
| Q24598357 | Cell signaling by receptor tyrosine kinases |
| Q30439922 | Cellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction |
| Q24322725 | Characterization of the human sulfatase Sulf1 and its high affinity heparin/heparan sulfate interaction domain |
| Q34003880 | Chemically oversulfated glycosaminoglycans are potent modulators of contact system activation and different cell signaling pathways |
| Q28592579 | Cloning, Golgi localization, and enzyme activity of the full-length heparin/heparan sulfate-glucuronic acid C5-epimerase |
| Q53219891 | Coacervate delivery of HB-EGF accelerates healing of type 2 diabetic wounds |
| Q45800889 | Comparative study of Plasmodium falciparum erythrocyte membrane protein 1-DBLα domain variants with respect to antigenic variations and docking interaction analysis with glycosaminoglycans |
| Q90132877 | Comparison of the Interactions of Different Growth Factors and Glycosaminoglycans |
| Q37490816 | Complexity in biomaterials for tissue engineering. |
| Q38331843 | Conformational selection of the AGA*IA(M) heparin pentasaccharide when bound to the fibroblast growth factor receptor. |
| Q33603057 | Control growth factor release using a self-assembled [polycation:heparin] complex |
| Q42801360 | Control of fibroblast growth factor (FGF) 7- and FGF1-induced mitogenesis and downstream signaling by distinct heparin octasaccharide motifs |
| Q50954909 | Controlled delivery of platelet-derived proteins enhances porcine wound healing |
| Q27321295 | Controlled delivery of sonic hedgehog morphogen and its potential for cardiac repair |
| Q38320039 | Cooperative dimerization of fibroblast growth factor 1 (FGF1) upon a single heparin saccharide may drive the formation of 2:2:1 FGF1.FGFR2c.heparin ternary complexes |
| Q39900683 | Cooperative heparin-mediated oligomerization of fibroblast growth factor-1 (FGF1) precedes recruitment of FGFR2 to ternary complexes. |
| Q92043470 | Cross-Talk between Fibroblast Growth Factor Receptors and Other Cell Surface Proteins |
| Q27639609 | Crystal structure of a C-terminal fragment of growth arrest-specific protein Gas6. Receptor tyrosine kinase activation by laminin G-like domains |
| Q24307630 | Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha |
| Q27637549 | Crystal structure of imaginal disc growth factor-2. A member of a new family of growth-promoting glycoproteins from Drosophila melanogaster |
| Q24531430 | Crystal structure of the OpcA integral membrane adhesin from Neisseria meningitidis |
| Q27639866 | Crystal structure of the TSP-1 type 1 repeats |
| Q24307661 | Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains |
| Q27635335 | Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor. |
| Q40632639 | Decapeptide with fibroblast growth factor (FGF)‐5 partial sequence inhibits hair growth suppressing activity of FGF‐5 |
| Q38989457 | Deciphering the mechanism behind Fibroblast Growth Factor (FGF) induced biphasic signal-response profiles |
| Q38194193 | Demystifying heparan sulfate-protein interactions. |
| Q38294596 | Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes |
| Q42389690 | Differential involvement of the extracellular 6-O-endosulfatases Sulf1 and Sulf2 in brain development and neuronal and behavioural plasticity |
| Q44473528 | Differential tyrosine phosphorylation of fibroblast growth factor (FGF) receptor-1 and receptor proximal signal transduction in response to FGF-2 and heparin |
| Q27650780 | Dimerization effect of sucrose octasulfate on rat FGF1 |
| Q24336141 | Direct binding of integrin alphavbeta3 to FGF1 plays a role in FGF1 signaling |
| Q48216911 | Distinctive expression patterns of heparan sulfate O-sulfotransferases and regional differences in heparan sulfate structure in chick limb buds |
| Q36407996 | Diversification of the structural determinants of fibroblast growth factor-heparin interactions: implications for binding specificity |
| Q38324891 | Dynamic properties of biologically active synthetic heparin-like hexasaccharides |
| Q36016804 | Dynamics and Distribution of Klothoβ (KLB) and Fibroblast Growth Factor Receptor-1 (FGFR1) in Living Cells Reveal the Fibroblast Growth Factor-21 (FGF21)-induced Receptor Complex |
| Q35061957 | Ectopic expression screen identifies genes affecting Drosophila mesoderm development including the HSPG Trol |
| Q24318815 | Effect of FGF-binding protein 3 on vascular permeability |
| Q48188858 | Effect of Preorganized Charge-Display on the Cell-Penetrating Properties of Cationic Peptides |
| Q54967453 | Effect of extension of the heparin binding pocket on the structure, stability, and cell proliferation activity of the human acidic fibroblast growth factor. |
| Q47810610 | Effects of Prisma® Skin dermal regeneration device containing glycosaminoglycans on human keratinocytes and fibroblasts. |
| Q28655742 | Efficient production and purification of recombinant human interleukin-12 (IL-12) overexpressed in mammalian cells without affinity tag |
| Q33891467 | Efficient production of human acidic fibroblast growth factor in pea (Pisum sativum L.) plants by agroinfection of germinated seeds |
| Q50790748 | Electrochemical control of growth factor presentation to steer neural stem cell differentiation. |
| Q35049136 | Elucidating glycosaminoglycan-protein-protein interactions using carbohydrate microarray and computational approaches. |
| Q42200380 | Elucidation of the mechanism of the regulatory function of the Ig1 module of the fibroblast growth factor receptor 1. |
| Q35967045 | Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall |
| Q27671505 | Engineered variants of InlB with an additional leucine‐rich repeat discriminate between physiologically relevant and packing contacts in crystal structures of the InlB:MET complex |
| Q51986250 | Essential role of heparan sulfate 2-O-sulfotransferase in chick limb bud patterning and development. |
| Q90173858 | Evaluation of a cell model expressing βKlotho for screening FGF21 analogues |
| Q38293475 | Evidence that heparin saccharides promote FGF2 mitogenesis through two distinct mechanisms |
| Q41948052 | Experimental support for the foldability-function tradeoff hypothesis: segregation of the folding nucleus and functional regions in fibroblast growth factor-1 |
| Q41973662 | Expression of hindbrain boundary markers is regulated by FGF3. |
| Q33897755 | Extended N-sulfated domains reside at the nonreducing end of heparan sulfate chains. |
| Q26851937 | Extracellular distribution of diffusible growth factors controlled by heparan sulfate proteoglycans during mammalian embryogenesis |
| Q24314647 | FGF-10 and its receptor exhibit bidirectional paracrine targeting to urothelial and smooth muscle cells in the lower urinary tract |
| Q35921407 | FGF23, hypophosphatemia, and rickets: has phosphatonin been found? |
| Q30585367 | FGF5 is a crucial regulator of hair length in humans |
| Q47182940 | FGF8 morphogen gradients are differentially regulated by heparan sulphotransferases Hs2st and Hs6st1 in the developing brain |
| Q34926833 | FGFs, their receptors, and human limb malformations: clinical and molecular correlations |
| Q30568524 | Fell-Muir Lecture: Heparan sulphate and the art of cell regulation: a polymer chain conducts the protein orchestra |
| Q92879928 | Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors |
| Q58377532 | Fibroblast Growth Factor Receptors 1 and 2 Interact Differently with Heparin/Heparan Sulfate |
| Q24305543 | Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs |
| Q42820903 | Fibroblast growth factor (FGF)-21 signals through both FGF receptor-1 and 2 |
| Q30444353 | Fibroblast growth factor 2 induced proliferation in osteoblasts and bone marrow stromal cells: a whole cell model |
| Q36083438 | Fibroblast growth factor signaling and the function and assembly of basement membranes |
| Q38203285 | Fibroblast growth factor signaling in liver carcinogenesis |
| Q24534355 | Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts |
| Q33897866 | Fibroblast growth factor-23 increases mouse PGE2 production in vivo and in vitro |
| Q37683396 | Fibroblast growth factor-based signaling through synthetic heparan sulfate blocks copolymers studied using high cell density three-dimensional cell printing |
| Q46805453 | Fibroblast growth factor-derived peptides: functional agonists of the fibroblast growth factor receptor |
| Q31153852 | Fibroblast growth factors share binding sites in heparan sulphate |
| Q33246009 | Finding a needle in a haystack: development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s). |
| Q27026070 | Functional augmentation of naturally-derived materials for tissue regeneration |
| Q34267718 | Functional map and domain structure of MET, the product of the c- met protooncogene and receptor for hepatocyte growth factor/scatter factor |
| Q35903268 | Functional overlap between chondroitin and heparan sulfate proteoglycans during VEGF-induced sprouting angiogenesis |
| Q36282338 | Functions and regulations of fibroblast growth factor signaling during embryonic development |
| Q47148090 | Gas-Phase Analysis of the Complex of Fibroblast GrowthFactor 1 with Heparan Sulfate: A Traveling Wave Ion Mobility Spectrometry (TWIMS) and Molecular Modeling Study |
| Q33551154 | Generating heparan sulfate saccharide libraries for glycomics applications. |
| Q38106582 | Generation and interpretation of FGF morphogen gradients in vertebrates |
| Q28344714 | Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis |
| Q24298832 | Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo fibroblast growth factor inhibitors |
| Q40387355 | Glial cell line-derived neurotrophic factor-induced signaling in Schwann cells. |
| Q35906116 | Glycomics: a pathway to a class of new and improved therapeutics |
| Q47897300 | Glycosidase Inhibition by Multivalent Presentation of Heparan Sulfate Saccharides on Bottlebrush Polymers. |
| Q35618921 | Glycosylated synaptomatrix regulation of trans‐synaptic signaling |
| Q24674858 | Glypican-1 is frequently overexpressed in human gliomas and enhances FGF-2 signaling in glioma cells |
| Q34600765 | Glypican-5 stimulates rhabdomyosarcoma cell proliferation by activating Hedgehog signaling |
| Q28344801 | Heparan Sulfate Proteoglycans as Regulators of Fibroblast Growth Factor-2 Receptor Binding in Breast Carcinomas |
| Q30433400 | Heparan sulfate acts as a bone morphogenetic protein coreceptor by facilitating ligand-induced receptor hetero-oligomerization |
| Q26796383 | Heparan sulfate and heparin interactions with proteins |
| Q31085481 | Heparan sulfate biosynthesis: methods for investigation of the heparanosome |
| Q37241414 | Heparan sulfate deficiency leads to Peters anomaly in mice by disturbing neural crest TGF-beta2 signaling |
| Q33615579 | Heparan sulfate domain organization and sulfation modulate FGF-induced cell signaling |
| Q34989559 | Heparan sulfate fine structure and specificity of proteoglycan functions |
| Q38154506 | Heparan sulfate in angiogenesis: a target for therapy |
| Q35842237 | Heparan sulfate is essential for high mobility group protein 1 (HMGB1) signaling by the receptor for advanced glycation end products (RAGE). |
| Q37093622 | Heparan sulfate on intestinal epithelial cells plays a critical role in intestinal crypt homeostasis via Wnt/β-catenin signaling |
| Q34989550 | Heparan sulfate proteoglycan modulation of developmental signaling in Drosophila |
| Q38747421 | Heparan sulfate proteoglycans as key regulators of the mesenchymal niche of hematopoietic stem cells. |
| Q34328750 | Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena |
| Q37590177 | Heparan sulfate proteoglycans: structure, protein interactions and cell signaling |
| Q34452740 | Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability. |
| Q40724152 | Heparan sulfate-growth factor interactions |
| Q38134808 | Heparan sulfate-protein binding specificity |
| Q38311931 | Heparan sulfate-related oligosaccharides in ternary complex formation with fibroblast growth factors 1 and 2 and their receptors |
| Q31882323 | Heparan sulfate: decoding a dynamic multifunctional cell regulator |
| Q34328757 | Heparan sulfate: growth control with a restricted sequence menu |
| Q83229441 | Heparan sulfates are critical regulators of the inhibitory megakaryocyte-platelet receptor G6b-B |
| Q36216124 | Heparan sulphate proteoglycans: the sweet side of development |
| Q77198342 | Heparin Binding Stabilizes the Membrane-bound Form of Cobra Cardiotoxin |
| Q39111023 | Heparin Modulates the Mitogenic Activity of Fibroblast Growth Factor by Inducing Dimerization of its Receptor. A 3D View by Using NMR |
| Q38290891 | Heparin amplifies platelet-derived growth factor (PDGF)- BB-induced PDGF alpha -receptor but not PDGF beta -receptor tyrosine phosphorylation in heparan sulfate-deficient cells. Effects on signal transduction and biological responses |
| Q37416889 | Heparin-Mimicking Polymers: Synthesis and Biological Applications |
| Q35825233 | Heparin-binding domains in vascular biology |
| Q27649238 | Heparin-induced cis- and trans-Dimerization Modes of the Thrombospondin-1 N-terminal Domain |
| Q35030190 | Heparin-protein interactions |
| Q38418286 | Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use. |
| Q58792047 | Heparin: role in protein purification and substitution with animal-component free material |
| Q92152542 | Heparinoid Complex-Based Heparin-Binding Cytokines and Cell Delivery Carriers |
| Q30331190 | High-throughput crystallography for lead discovery in drug design. |
| Q33864454 | Highly sulfated nonreducing end-derived heparan sulfate domains bind fibroblast growth factor-2 with high affinity and are enriched in biologically active fractions |
| Q44428763 | Identification of a key structural element for protein folding within beta-hairpin turns |
| Q36403611 | Identification of proteoglycans as the APRIL-specific binding partners. |
| Q24550863 | Identification of receptor and heparin binding sites in fibroblast growth factor 4 by structure-based mutagenesis |
| Q35871318 | Identification of the Glycosaminoglycan Binding Site of Interleukin-10 by NMR Spectroscopy |
| Q38305855 | Importance of the polarity of the glycosaminoglycan chain on the interaction with FGF-1. |
| Q42576867 | Increased protein stability of FGF1 can compensate for its reduced affinity for heparin |
| Q38343318 | Influence of heparin mimetics on assembly of the FGF.FGFR4 signaling complex. |
| Q40337083 | Inhibition or activation of Apert syndrome FGFR2 (S252W) signaling by specific glycosaminoglycans |
| Q44019621 | Interaction of the IP(3)-Ca(2+) and the FGF-MAPK signaling pathways in the Xenopus laevis embryo: a qualitative approach to the mesodermal induction problem |
| Q37543699 | Interactions between heparan sulfate and proteins-design and functional implications |
| Q46835307 | Interactions of hepatocyte growth factor/scatter factor with various glycosaminoglycans reveal an important interplay between the presence of iduronate and sulfate density. |
| Q52323943 | Investigating the Dynamics and Polyanion Binding Sites of Fibroblast Growth Factor-1 Using Hydrogen-Deuterium Exchange Mass Spectrometry |
| Q35886618 | Kallmann syndrome: fibroblast growth factor signaling insufficiency? |
| Q28278567 | Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair |
| Q37257393 | Lack of L-iduronic acid in heparan sulfate affects interaction with growth factors and cell signaling |
| Q27640887 | Leads for development of new naphthalenesulfonate derivatives with enhanced antiangiogenic activity: crystal structure of acidic fibroblast growth factor in complex with 5-amino-2-naphthalene sulfonate |
| Q38357058 | Loss of ligand-binding specificity of fibroblast growth factor receptor 2 by RNA splicing in human chondrosarcoma cells |
| Q34652072 | Mammalian heparanase: what is the message? |
| Q26774227 | Marine Non-Glycosaminoglycan Sulfated Glycans as Potential Pharmaceuticals |
| Q38603626 | Mechanisms of FGF gradient formation during embryogenesis |
| Q35764259 | Mechanistic diversity of cytokine receptor signaling across cell membranes |
| Q52129710 | Membrane heparan sulfate proteoglycan-supported FGF2-FGFR1 signaling: evidence in support of the "cooperative end structures" model |
| Q39676210 | Metabolic regulator betaKlotho interacts with fibroblast growth factor receptor 4 (FGFR4) to induce apoptosis and inhibit tumor cell proliferation |
| Q39340491 | MicroRNA-125a inhibits cell growth by targeting glypican-4 |
| Q42587744 | MicroRNA-24 suppression of N-deacetylase/N-sulfotransferase-1 (NDST1) reduces endothelial cell responsiveness to vascular endothelial growth factor A (VEGFA). |
| Q38205436 | Molecular Interactions between Complement Factor H and Its Heparin and Heparan Sulfate Ligands. |
| Q34310374 | Molecular diversity of heparan sulfate |
| Q24338718 | Molecular mechanism of SSR128129E, an extracellularly acting, small-molecule, allosteric inhibitor of FGF receptor signaling |
| Q28291993 | Molecular mechanisms of fibroblast growth factor signaling in physiology and pathology |
| Q51568879 | Molecular modeling of the interaction between heparan sulfate and cellular growth factors: bringing pieces together |
| Q43197470 | Multimers of the fibroblast growth factor (FGF)-FGF receptor-saccharide complex are formed on long oligomers of heparin. |
| Q38343547 | Multiple mechanisms for exogenous heparin modulation of vascular endothelial growth factor activity |
| Q36851279 | Multivalent proteoglycan modulation of FGF mitogenic responses in perivascular cells. |
| Q48081952 | Mutant analyses reveal different functions of fgfr1 in medaka and zebrafish despite conserved ligand-receptor relationships |
| Q37446013 | N-Glycosylation regulates fibroblast growth factor receptor/EGL-15 activity in Caenorhabditis elegans in vivo |
| Q28250986 | N-glycosylation of fibroblast growth factor receptor 1 regulates ligand and heparan sulfate co-receptor binding |
| Q30159788 | NMR structure of the first Ig module of mouse FGFR1 |
| Q28298433 | Netrin-1/DCC signaling in commissural axon guidance requires cell-autonomous expression of heparan sulfate |
| Q98771678 | Neurogenesis From Neural Crest Cells: Molecular Mechanisms in the Formation of Cranial Nerves and Ganglia |
| Q38081956 | New targets for glycosaminoglycans and glycosaminoglycans as novel targets. |
| Q24336798 | Novel mechanisms of fibroblast growth factor receptor 1 regulation by extracellular matrix protein anosmin-1 |
| Q30376698 | Novel phosphotyrosine targets of FGFR2IIIb signaling. |
| Q38342027 | Octasaccharide is the minimal length unit required for efficient binding of cyclophilin B to heparin and cell surface heparan sulphate. |
| Q46050552 | On the role of glypicans in the process of morphogen gradient formation |
| Q34489551 | Order out of complexity – protein structures that interact with heparin |
| Q42318227 | Overexpression of heparanase attenuated TGF-β-stimulated signaling in tumor cells |
| Q30368988 | Overview of protein structural and functional folds. |
| Q26823840 | Pathophysiology of heparan sulphate: many diseases, few drugs |
| Q36014585 | Pentosan polysulfate increases affinity between ADAMTS-5 and TIMP-3 through formation of an electrostatically driven trimolecular complex |
| Q35562693 | Perlecan and tumor angiogenesis |
| Q42834531 | Peroxynitrite modulates acidic fibroblast growth factor (FGF-1) activity |
| Q34030128 | Phosphatonin washout in Hyp mice proximal tubules: evidence for posttranscriptional regulation |
| Q41851531 | Pigment Epithelium-derived Factor (PEDF) Shares Binding Sites in Collagen with Heparin/Heparan Sulfate Proteoglycans |
| Q35773099 | Polyanions and the proteome |
| Q46165924 | Predicting glycosaminoglycan surface protein interactions and implications for studying axonal growth |
| Q43568416 | Probing fibroblast growth factor dimerization and role of heparin-like glycosaminoglycans in modulating dimerization and signaling |
| Q90384999 | Probing the role of proline -135 on the structure, stability, and cell proliferation activity of human acidic fibroblast growth factor |
| Q44210624 | Protein-heparin interactions measured by BIAcore 2000 are affected by the method of heparin immobilization |
| Q57376619 | Protein–polyelectrolyte interactions |
| Q36182371 | Proteoglycan sequence |
| Q41978020 | Proteoglycans and their heterogeneous glycosaminoglycans at the atomic scale |
| Q34362776 | Proteoglycans: pericellular and cell surface multireceptors that integrate external stimuli in the mammary gland |
| Q37415156 | QSulf1, a heparan sulfate 6-O-endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis |
| Q35041008 | ROS-DET: robust detector of switching mechanisms in gene expression |
| Q40983650 | Recombinant expression in E. coli of human FGFR2 with its transmembrane and extracellular domains |
| Q36477003 | Redesigning symmetry-related "mini-core" regions of FGF-1 to increase primary structure symmetry: thermodynamic and functional consequences of structural symmetry. |
| Q35151453 | Regulation of phosphate transport by fibroblast growth factor 23 (FGF23): implications for disorders of phosphate metabolism |
| Q33716980 | Role of FGFR2-signaling in the pathogenesis of acne |
| Q40205574 | Role of constraint in catalysis and high-affinity binding by proteins |
| Q36294136 | Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition |
| Q34361094 | Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function |
| Q34489556 | Role of heparan sulfate in fibroblast growth factor signalling: a structural view |
| Q34414667 | Role of heparan sulfate proteoglycans in cell signaling and cancer |
| Q33846467 | SCUBE3 (signal peptide-CUB-EGF domain-containing protein 3) modulates fibroblast growth factor signaling during fast muscle development |
| Q34610559 | Screening a phage display library for a novel FGF8b-binding peptide with anti-tumor effect on prostate cancer |
| Q37021165 | Secreted proteoglycans directly mediate human embryonic stem cell-basic fibroblast growth factor 2 interactions critical for proliferation |
| Q21144445 | Secreted sulfatases Sulf1 and Sulf2 have overlapping yet essential roles in mouse neonatal survival |
| Q43678259 | Sequence analyses and comparative modeling of fly and worm fibroblast growth factor receptors indicate that the determinants for FGF and heparin binding are retained in evolution |
| Q43640409 | Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2. |
| Q41915622 | Sequence swapping does not result in conformation swapping for the beta4/beta5 and beta8/beta9 beta-hairpin turns in human acidic fibroblast growth factor. |
| Q42158243 | Sequential Delivery of Basic Fibroblast Growth Factor and Platelet-Derived Growth Factor for Angiogenesis |
| Q84602180 | Simultaneous determination of uronates found in polysaccharides from natural products by HPLC with fluorometric detection |
| Q37417671 | Single-Molecule Fluorescence Detection of a Synthetic Heparan Sulfate Disaccharide |
| Q36410019 | Solid-Phase Synthesis of 2-Aminoethyl Glucosamine Sulfoforms |
| Q38309317 | Solution NMR structure of a human FGF-1 monomer, activated by a hexasaccharide heparin-analogue. |
| Q74086594 | Solution structure and interaction with basic and acidic fibroblast growth factor of a 3-kDa human platelet factor-4 fragment with antiangiogenic activity |
| Q48526269 | Spatial and temporal organization of multi-protein assemblies: achieving sensitive control in information-rich cell-regulatory systems |
| Q90445879 | Specific Inhibition of Heparanase by a Glycopolymer with Well-Defined Sulfation Pattern Prevents Breast Cancer Metastasis in Mice |
| Q33317125 | Specific heparan sulfate structures modulate FGF10-mediated submandibular gland epithelial morphogenesis and differentiation |
| Q41995092 | Src kinase modulates the activation, transport and signalling dynamics of fibroblast growth factor receptors |
| Q27650132 | Structural and Functional Analysis of Slit and Heparin Binding to Immunoglobulin-like Domains 1 and 2 of Drosophila Robo |
| Q24294933 | Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors |
| Q34442255 | Structural basis for activation of fibroblast growth factor signaling by sucrose octasulfate |
| Q46639843 | Structural basis for antagonism by suramin of heparin binding to vaccinia complement protein |
| Q24291302 | Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome |
| Q42794106 | Structural basis for the activation of FGFR by NCAM. |
| Q24304947 | Structural basis for the inhibition of activin signalling by follistatin. |
| Q34572895 | Structural basis of hepatocyte growth factor/scatter factor and MET signalling |
| Q36416631 | Structural biology and bioinformatics in drug design: opportunities and challenges for target identification and lead discovery |
| Q27680033 | Structural insights into proteoglycan-shaped Hedgehog signaling |
| Q24293266 | Structural insights into the Slit-Robo complex |
| Q34805392 | Structural specificity of heparin binding in the fibroblast growth factor family of proteins |
| Q34523315 | Structure and biological interactions of heparin and heparan sulfate |
| Q27643740 | Structure of rat acidic fibroblast growth factor at 1.4 Å resolution |
| Q60302361 | Structure, activation and dysregulation of fibroblast growth factor receptor kinases: perspectives for clinical targeting |
| Q40629003 | Structure-based mutational analyses in FGF7 identify new residues involved in specific interaction with FGFR2IIIb |
| Q44046272 | Study of the interaction of the Ig2 module of the fibroblast growth factor receptor, FGFR Ig2, with the fibroblast growth factor 1, FGF1, by means of NMR spectroscopy |
| Q34044419 | Sulfatase modifying factor 1-mediated fibroblast growth factor signaling primes hematopoietic multilineage development |
| Q40630770 | Sulfated Derivatives of Escherichia coli K5 Polysaccharides as Modulators of Fibroblast Growth Factor Signaling |
| Q100455198 | Sulfated glycans engage the Ang-Tie pathway to regulate vascular development |
| Q24306135 | Sulfated glycosaminoglycans are required for specific and sensitive fibroblast growth factor (FGF) 19 signaling via FGF receptor 4 and betaKlotho |
| Q52125404 | Syndecan-3 and Syndecan-4 Specifically Mark Skeletal Muscle Satellite Cells and Are Implicated in Satellite Cell Maintenance and Muscle Regeneration |
| Q34578755 | Synthesis of a heparin-related GlcN-IdoA sulfation-site variable disaccharide library and analysis by Raman and ROA spectroscopy |
| Q79230764 | Synthesis of heparin-like oligosaccharides on a soluble polymer support |
| Q80866631 | Synthesis of heparin-like oligosaccharides on polymer supports |
| Q38329756 | Synthesis of heparinoligosaccharides and their interaction with eosinophil-derived neurotoxin |
| Q36430287 | Synthetic multivalent ligands as probes of signal transduction |
| Q33720798 | Targeted analysis of glycomics liquid chromatography/mass spectrometry data |
| Q85093998 | The 2SO Skew‐Boat Conformation in L‐Iduronic Acid |
| Q27640861 | The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly |
| Q37810999 | The Dynamic Glycome Microenvironment and Stem Cell Differentiation into Vasculature |
| Q55318767 | The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells. |
| Q52745437 | The Hydra FGFR, Kringelchen, partially replaces the Drosophila Heartless FGFR |
| Q44504094 | The N-terminal domain of hepatocyte growth factor inhibits the angiogenic behavior of endothelial cells independently from binding to the c-met receptor |
| Q44406770 | The amino acid sequences of the carboxyl termini of human and mouse hepatic lipase influence cell surface association |
| Q41006430 | The collαgen III fibril has a "flexi-rod" structure of flexible sequences interspersed with rigid bioactive domains including two with hemostatic roles |
| Q41480664 | The conundrum of the high-affinity NGF binding site formation unveiled? |
| Q40795261 | The cytoplasmic and transmembrane domains of the p75 and Trk A receptors regulate high affinity binding to nerve growth factor. |
| Q40226973 | The fibroblast growth factor receptor acid box is essential for interactions with N-cadherin and all of the major isoforms of neural cell adhesion molecule |
| Q34029195 | The heparan sulfate co-receptor and the concentration of fibroblast growth factor-2 independently elicit different signalling patterns from the fibroblast growth factor receptor |
| Q40668417 | The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex |
| Q40171449 | The major determinant of the heparin binding of glial cell-line-derived neurotrophic factor is near the N-terminus and is dispensable for receptor binding |
| Q30724190 | The mouse Fgfrl1 gene coding for a novel FGF receptor-like protein |
| Q28074145 | The rise of the FGFR inhibitor in advanced biliary cancer: the next cover of time magazine? |
| Q60482229 | The solution structure of heparan sulfate differs from that of heparin: implications for function |
| Q35107450 | The solution structure of heparan sulfate differs from that of heparin: implications for function. |
| Q34474956 | The specificity of interactions between proteins and sulfated polysaccharides |
| Q44368469 | The structural biology of growth factor receptor activation |
| Q44701834 | The transmembrane protein XFLRT3 forms a complex with FGF receptors and promotes FGF signalling |
| Q43855560 | Thyroid status affects number and localization of thyroid hormone receptor expressing mast cells in bone marrow |
| Q36509470 | Understanding cytokine and growth factor receptor activation mechanisms |
| Q44581081 | Visualization and characterization of receptor clusters by transmission electron microscopy |
| Q37119853 | WITHDRAWN: NCAM and the FGF-Receptor |
| Q34011254 | Zebrafish Ext2 is necessary for Fgf and Wnt signaling, but not for Hh signaling |
| Q50001744 | α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling |
Search more.